Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

243 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reevaluating Disease-Free Survival as an Endpoint vs Overall Survival in Stage III Adjuvant Colon Cancer Trials.
Yin J, Salem ME, Dixon JG, Jin Z, Cohen R, DeGramont A, Van Cutsem E, Taieb J, Alberts SR, Wolmark N, Schmoll HJ, Saltz LB, George TJ, Goldberg RRM, Kerr R, Lonardi S, Yoshino T, Yothers G, Grothey A, Andre T, Shi Q. Yin J, et al. Among authors: alberts sr. J Natl Cancer Inst. 2022 Jan 11;114(1):60-67. doi: 10.1093/jnci/djab187. J Natl Cancer Inst. 2022. PMID: 34505880 Free PMC article.
Comparison of estrogen receptor determinations by a biochemical ligand-binding assay and immunohistochemical staining with monoclonal antibody ER1D5 in females with lymph node positive breast carcinoma entered on two prospective clinical trials.
Alberts SR, Ingle JN, Roche PR, Cha SS, Wold LE, Farr GH Jr, Krook JE, Wieand HS. Alberts SR, et al. Cancer. 1996 Aug 15;78(4):764-72. doi: 10.1002/(SICI)1097-0142(19960815)78:4<764::AID-CNCR12>3.0.CO;2-T. Cancer. 1996. PMID: 8756370
Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
Gill S, Loprinzi CL, Sargent DJ, Thomé SD, Alberts SR, Haller DG, Benedetti J, Francini G, Shepherd LE, Francois Seitz J, Labianca R, Chen W, Cha SS, Heldebrant MP, Goldberg RM. Gill S, et al. Among authors: alberts sr. J Clin Oncol. 2004 May 15;22(10):1797-806. doi: 10.1200/JCO.2004.09.059. Epub 2004 Apr 5. J Clin Oncol. 2004. PMID: 15067028
Metastatic colorectal cancer: Therapeutic options.
Patiyil S, Alberts SR. Patiyil S, et al. Among authors: alberts sr. Curr Treat Options Oncol. 2006 Sep;7(5):389-98. doi: 10.1007/s11864-006-0007-8. Curr Treat Options Oncol. 2006. PMID: 16904056 Review.
Updated efficacy and toxicity analysis of irinotecan and oxaliplatin (IROX) : intergroup trial N9741 in first-line treatment of metastatic colorectal cancer.
Ashley AC, Sargent DJ, Alberts SR, Grothey A, Campbell ME, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK, Findlay BP, Pitot HC, Goldberg RM. Ashley AC, et al. Among authors: alberts sr. Cancer. 2007 Aug 1;110(3):670-7. doi: 10.1002/cncr.22831. Cancer. 2007. PMID: 17559146 Free article. Clinical Trial.
243 results